Singapore markets close in 33 minutes
  • Straits Times Index

    3,292.50
    -2.32 (-0.07%)
     
  • Nikkei

    27,522.26
    -250.67 (-0.90%)
     
  • Hang Seng

    24,965.55
    +13.20 (+0.05%)
     
  • FTSE 100

    7,516.64
    -68.37 (-0.90%)
     
  • BTC-USD

    39,111.45
    -2,842.00 (-6.77%)
     
  • CMC Crypto 200

    924.29
    -70.98 (-7.13%)
     
  • S&P 500

    4,482.73
    -50.03 (-1.10%)
     
  • Dow

    34,715.39
    -313.26 (-0.89%)
     
  • Nasdaq

    14,154.02
    -186.23 (-1.30%)
     
  • Gold

    1,833.00
    -9.60 (-0.52%)
     
  • Crude Oil

    86.29
    -0.61 (-0.70%)
     
  • 10-Yr Bond

    1.8330
    0.0000 (0.00%)
     
  • FTSE Bursa Malaysia

    1,522.14
    -5.61 (-0.37%)
     
  • Jakarta Composite Index

    6,726.37
    +99.50 (+1.50%)
     
  • PSE Index

    7,293.52
    +54.24 (+0.75%)
     
DEALS:

Singtel takes 16.3% stake in Indonesia's Bank Fama for S$48 million

Certara to Host Investor Day on December 15, 2021

  • Oops!
    Something went wrong.
    Please try again later.
·1-min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • CERT

PRINCETON, N.J., Dec. 08, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, will host an Investor Day on Wednesday, December 15, 2021 from 3:00 PM to 6:00 PM ET in New York City. Certara’s management team will provide updates on the Company’s strategy, differentiated software and technology-driven services, and financial guidance for 2022. There will also be a demonstration of the Simcyp™ Simulator.

The live video webcast of the event, along with a slide presentation, will be available on Certara's Investor Relations website at https://ir.certara.com/events/event-details/certara-investor-day. A replay of the event will be archived on the Investor Relations website for 2 weeks following the event.

About Certara
Certara accelerates medicines using proprietary biosimulation software and technology to transform traditional drug discovery and development. Its clients include more than 1,650 global biopharmaceutical companies, leading academic institutions, and key regulatory agencies across 61 countries.

Certara Contact
Jieun W. Choe
jieun.choe@certara.com

Media Contacts:
Daniel Yunger
Kekst CNC
daniel.yunger@kekstcnc.com

Investor Relations Contact:
David Deuchler
Gilmartin Group
ir@certara.com


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting